| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/23/2002 | WO2002040703A1 System and method for identifying and isolating rare cells from a mixed population of cells |
| 05/23/2002 | WO2002040702A2 Methods for the treatment of cancer and other diseases and methods of developing the same |
| 05/23/2002 | WO2002040701A2 Energy transfer labels with mechanically linked fluorophores |
| 05/23/2002 | WO2002040699A2 Sampling and storage system for genetic material from tissue |
| 05/23/2002 | WO2002040698A2 Analysis of soluble factor biological markers |
| 05/23/2002 | WO2002040690A2 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |
| 05/23/2002 | WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | WO2002040677A2 Cotton event pv-ghbk04 (531) and compositions and methods for detection thereof |
| 05/23/2002 | WO2002040673A2 Compositions and methods relating to lung specific genes and proteins |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040663A1 Nucleic acids for detecting fungi and method of detecting fungi by using the same |
| 05/23/2002 | WO2002040660A2 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040648A1 T cell line and use thereof |
| 05/23/2002 | WO2002040638A2 Mycologic genera specific selective agar and method of manufacture |
| 05/23/2002 | WO2002040542A2 58569 and 50111, human anion exchange proteins and methods of use thereof |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 05/23/2002 | WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | WO2002040503A2 Haplotypes of the plau gene |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040242A1 Electroprocessed collagen |
| 05/23/2002 | WO2002040126A2 Methods for identifying nucleotides at defined positions in target nucleic acids using fluorescence polarization |
| 05/23/2002 | WO2002039990A2 Method for screening anti-proliferative compounds and inhibiting tumor growth |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039808A1 Method of enhancing virus-resistance in plants and producing virus-immune plants |
| 05/23/2002 | WO2002016904A3 Microfluidic device and method with transport of magnetic particles into and out of wells |
| 05/23/2002 | WO2002004595A3 Production of chimeric human papillomavirus |
| 05/23/2002 | WO2002000931A3 Sample generation for genotyping by mass spectrometry |
| 05/23/2002 | WO2001098315A3 Haplotypes of the hmgcl gene |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001096595A3 Method for the detection of influenza a/b viruses in saliva |
| 05/23/2002 | WO2001095860A3 Probes for chondrogenesis |
| 05/23/2002 | WO2001094364A3 Haplotypes of the csf3 gene |
| 05/23/2002 | WO2001092552A3 Method for the purification of alphavirus replicon particles |
| 05/23/2002 | WO2001091625A3 Methods and compositions for the diagnosis of schizophrenia |
| 05/23/2002 | WO2001088178A3 Peptide substrates for direct measuring of enzyme activities |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001086299A3 Doped nanoparticles as biolabels |
| 05/23/2002 | WO2001085990A3 Method and device for separating marked biopolymers |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085741A3 Haplotypes of the sod1 gene |
| 05/23/2002 | WO2001083691A3 System for identifying and analyzing expression of are-containing genes |
| 05/23/2002 | WO2001083621A3 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates |
| 05/23/2002 | WO2001082948A3 Uses of tgap7 for the modulation of leucocyte activation |
| 05/23/2002 | WO2001081603A3 Trophic conversion of obligate phototrophic algae through metabolic engineering |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001081549A3 Hepatocyte lineage cells derived from pluripotent stem cells |
| 05/23/2002 | WO2001081543A3 Multilocus repetitive dna sequences for genotyping bacillus anthracis and related bacteria |
| 05/23/2002 | WO2001080721A3 Methods and compositions for the diagnosis of schizophrenia |
| 05/23/2002 | WO2001075149A3 Biosensor, biosensor array and method for detecting macromolecular biopolymers with a biosensor |
| 05/23/2002 | WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 05/23/2002 | WO2001072837A3 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 05/23/2002 | WO2001064938A3 Enzymatic-electrochemical measuring device |
| 05/23/2002 | WO2001063295A3 Dpi-6, a therapeutic biomarker in neurological disorders |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001046461A3 Modified nucleic acids and their use |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001034773A9 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/23/2002 | WO2001032931A3 Method and compositions for selectively inhibiting amplification of sequences in a population of nucleic acid molecules |
| 05/23/2002 | WO2001031059A3 Genetic biosensors using chemiluminescence |
| 05/23/2002 | WO2001029261A3 A method for high-density microarray mediated gene expression profiling |
| 05/23/2002 | WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 05/23/2002 | WO2001020024A3 Method for determining nucleic and/or amino acid sequences |
| 05/23/2002 | WO2000066774A3 Improved assay and reagents therefor |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062319 Gene expression and evaluation system |
| 05/23/2002 | US20020062073 Chemical signal-impermeable mask |
| 05/23/2002 | US20020062016 Detection of Human Immunodeficiency Virus type 1 |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061860 Antisense oligonucleotide inhibition of specific histone deacetylase isoforms |
| 05/23/2002 | US20020061859 Antisense oligonucleotides and antibodies which inhibit its expression or biological activity |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061845 Diagnostic, screening and therapeutic utilization; caspase recruitment domain (CARD) proteins, polypeptides and nucleic acid molecules |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061836 Modifying drug pharmacokinetics by altering the activity of steroid xenobiotic receptor(SXR) on expression levels of CYP2C8 or MDR1 cytochrome |
| 05/23/2002 | US20020061833 Novel molecules of the card-related protein family and uses thereof |
| 05/23/2002 | US20020061591 Device for use biochemical conjugation |
| 05/23/2002 | US20020061586 Isolation of preferential aggregates in sample; obtain aggregates, transform, isolate aggregates expressing green fluorescent protein |
| 05/23/2002 | US20020061573 Nucleotide seqences which code enzymatic polypeptide for use in diagnosis and treatment of cell propagation defects, pain, eating, urogenital and brain disorders, cachexia and diabetes |
| 05/23/2002 | US20020061571 Novel isoform of myotonic dystrophy associated protein kinase and uses thereof |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061567 Nucleotide sequences coding polypeptide for use in diagnostics, forensics, gene mapping and detection of mutation |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061546 Assays for protein kinases using fluorescent protein substrates |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061543 Diagnosing cancer in humans; obtain tissue, monitor transcription factor expression, compare to control, amplified expression indicates cancer |
| 05/23/2002 | US20020061542 Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood |
| 05/23/2002 | US20020061541 Diagnosis of endometrial precancers |
| 05/23/2002 | US20020061540 Library; for use in drug screening and development |
| 05/23/2002 | US20020061538 Fluidic arrays |
| 05/23/2002 | US20020061537 Stabilization of nucleic acid amplification cocktails |
| 05/23/2002 | US20020061535 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals |
| 05/23/2002 | US20020061534 Apparatus for use in the accurate detection of preferential particles in sample |
| 05/23/2002 | US20020061533 Method for the non-specific amplification of nucleic acid |
| 05/23/2002 | US20020061532 Method and apparatus for performing amplification of nucleic acids on supports |
| 05/23/2002 | US20020061530 Enhanced targeting of DNA sequences by recombinase protein and single-stranded homologous DNA probes using DNA analog activation |